These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13478285)

  • 1. Necrotizing properties of metaraminol (aramine) and arterenol (norepinephrine); comparative study.
    BRYANT MF; HOWARD JM
    AMA Arch Surg; 1957 Dec; 75(6):1020-2. PubMed ID: 13478285
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject.
    MOYER JH; MORRIS G; SNYDER H; SMITH CP
    Circulation; 1954 Aug; 10(2):265-70. PubMed ID: 13182760
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of respiratory acidosis on ECG and pressor responses to epinephrine, norepinephrine and metaraminol.
    HOULE DB; WEIL MH; BROWN EB; CAMPBELL GS
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):561-4. PubMed ID: 13408326
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cardiac shock by metaraminol.
    BESTERMAN EM
    Br Med J; 1959 Apr; 1(5129):1081-3. PubMed ID: 13638636
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of coronary action of metaraminol and noradrenaline on the isolated heart.
    CAYUELA ML; DOUGLAS CR; TALESNIK J
    Acta Physiol Lat Am; 1961; 11():120-6. PubMed ID: 13877529
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in central blood volume and cardiac output induced by positive pressure breathing and counteracted by metaraminol (aramine).
    BRAUNWALD E; BINION JT; MORGAN WL; SARNOFF SJ
    Circ Res; 1957 Nov; 5(6):670-5. PubMed ID: 13473068
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical studies on a vasopressor agent: metaraminol (aramine). I. Observations in normotensive subjects.
    WEIL MH; SPINK WW
    Am J Med Sci; 1955 Jun; 229(6):661-9. PubMed ID: 14376394
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulatory depression induced by high levels of positive pressure breathing counteracted by metaraminol (aramine).
    MORGAN WL; BINION JT; SARNOFF SJ
    J Appl Physiol; 1957 Jan; 10(1):26-30. PubMed ID: 13405825
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of aramine, a new sympathomimetic amine.
    TAYLOR GW
    AMA Arch Otolaryngol; 1952 Aug; 56(2):213-4. PubMed ID: 14943343
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical studies on vasopressor agent: metaraminol (aramine). III. Observations on its oral use in the treatment of hypotension.
    WEIL MH
    Am J Med Sci; 1957 Apr; 233(4):367-74. PubMed ID: 13410911
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock.
    WEIL MH
    Am J Med Sci; 1955 Oct; 230(4):357-69. PubMed ID: 13258566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metaraminol (aramine) therapy of shock due to coronary occlusion].
    MUNE O; NORREGAARD S
    Nord Med; 1959 Aug; 62():1255-60. PubMed ID: 14425245
    [No Abstract]   [Full Text] [Related]  

  • 13. The cardiovascular and renal hemodynamic effects of aramine.
    LIVESAY WR; MOYER JH; CHAPMAN DW
    Am Heart J; 1954 May; 47(5):745-56. PubMed ID: 13148114
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of aramine in the treatment of shock.
    MOYER JH; BEAZLEY HL
    Am Heart J; 1955 Jul; 50(1):136-44. PubMed ID: 14387943
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of aramine on the survival of dogs subjected to hemorrhagic hypotension.
    SARNOFF SJ; KAUFMAN HE
    Circ Res; 1954 Sep; 2(5):420-3. PubMed ID: 13190623
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of aramine-induced smooth muscle contraction on length-tension diagrams of venous strips.
    LEONARD E; SARNOFF SJ
    Circ Res; 1957 Mar; 5(2):169-74. PubMed ID: 13414090
    [No Abstract]   [Full Text] [Related]  

  • 17. RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION.
    CROUT JR; ALPERS HS; TATUM EL; SHORE PA
    Science; 1964 Aug; 145(3634):828-9. PubMed ID: 14163327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular function. V. The circulatory effects of aramine; mechanism of action of vasopressor drugs in cardiogenic shock.
    SARNOFF SJ; CASE RB; BERGLUND E; SARNOFF LC
    Circulation; 1954 Jul; 10(1):84-93. PubMed ID: 13172865
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of aramine in clinical shock.
    FANKHAUSER A; FISHMAN SI; MADONIA PF; SCHWARTZ G; STECHEL GH; TURKOWITZ H
    Circulation; 1956 Jun; 13(6):834-6. PubMed ID: 13356437
    [No Abstract]   [Full Text] [Related]  

  • 20. Aramine peripheral vaso spastic effects during therapy. A case report.
    GERSON IM
    J Germantown Hosp; 1962 Aug; 3():93-6. PubMed ID: 13898081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.